Market Cap : 9.69 B | Enterprise Value : 9.52 B | PE Ratio : | PB Ratio : 46.98 |
---|
NAS:BBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BridgeBio Pharma's Accounts Payable for the quarter that ended in Sep. 2020 was $9.84 Mil.
BridgeBio Pharma's quarterly Accounts Payable declined from Mar. 2020 ($13.09 Mil) to Jun. 2020 ($12.84 Mil) and declined from Jun. 2020 ($12.84 Mil) to Sep. 2020 ($9.84 Mil).
BridgeBio Pharma's annual Accounts Payable increased from Dec. 2017 ($1.89 Mil) to Dec. 2018 ($13.51 Mil) but then declined from Dec. 2018 ($13.51 Mil) to Dec. 2019 ($8.85 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
No Headline